Table 1.
Relationship between expression of BAP31 levels in colorectal cancer and clinic pathological features (n = 57, *P < 0.05)
| Clinical characteristics | N (total %) | BAP31 relative expression | Statistic | P value | |
|---|---|---|---|---|---|
| Up-regulation N (total %) & (subject %) | Down-regulation N (total %) & (subject %) | ||||
| Age (years) | |||||
| ≥ 56 | 34 (59.65) | 28 (49.12) (82.35) | 6 (10.53) (17.65) | 1.274 | 0.339 |
| < 56 | 23 (40.35) | 16 (28.07) (69.57) | 7 (12.28) (30.43) | ||
| Gender | |||||
| Male | 30 (52.63) | 22 (38.60) (73.33) | 8 (14.4) (26.67) | 0.536 | 0.538 |
| Female | 27 (47.37) | 22 (38.60) (81.48) | 5 (8.77) (18.52) | ||
| Tumor location | |||||
| Rectum | 48 (84.21) | 37 (59.65) (77.08) | 11 (19.30) (22.92) | 0.002 | 1.000 |
| Colon | 9 (15.79) | 7 (12.28) (77.78) | 2 (3.51) (22.22) | ||
| Differentiation | |||||
| Low | 10 (17.54) | 6 (10.53) (60.00) | 4 (7.02) (40.00) | 2.036 | 0.213 |
| Middle | 47 (82.46) | 38 (66.67) (80.85) | 9 (15.79) (19.15) | ||
| Node status | |||||
| N0 | 30 (52.63) | 23 (40.35) (76.67) | 7 (12.28) (23.33) | 1.172 | 0.350 |
| N1–N2 | 27 (47.37) | 21 (36.84) (77.78) | 6 (10.53) (22.22) | ||
| Distant metastasis | |||||
| M0 | 50 (87.72) | 41 (71.93) (82.00) | 9 (15.79) (18.00) | 5.344 | 0.041* |
| M1 | 7 (12.28) | 3 (5.26) (42.86) | 4 (7.02) (57.14) | ||
| Clinical stage | |||||
| I | 3 (5.26) | 1 (1.75) (33.33) | 2 (3.51) (66.67) | 9.645 | 0.022* |
| II | 26 (45.61) | 22 (38.60) (84.62) | 4 (7.02) (15.38) | ||
| III | 21 (36.84) | 18 (31.58) (85.71) | 3 (5.26) (14.29) | ||
| IV | 7 (12.28) | 3 (5.26) (42.86) | 4 (7.02) (57.14) | ||